NCT03084419View on ClinicalTrials.gov

APRIL (AbatacePt in Rheumatoid Arthritis-ILD)

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Rheumatoid ArthritisInterstitial Lung Disease
Interventions
DRUG

Abatacept

"The IV dose varies according to weight:~\<60kg=500mg~≥60 but≤100kg=750mg \>100kg=1g~This equates to approximately 10mg/kg."

Trial Locations (2)

CB2 0QQ

RECRUITING

Addenbrookes Hospital, Cambridge

CB23 3RE

RECRUITING

Papworth Hospital, Cambridge

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER